TLX 4.14% $18.07 telix pharmaceuticals limited

Ann: Phase II study for indication expansion of TLX250-CDx doses

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.